METHYLDOPA AND CHLOROTHIAZIDE Drug Patent Profile
✉ Email this page to a colleague
When do Methyldopa And Chlorothiazide patents expire, and when can generic versions of Methyldopa And Chlorothiazide launch?
Methyldopa And Chlorothiazide is a drug marketed by Par Pharm and is included in two NDAs.
The generic ingredient in METHYLDOPA AND CHLOROTHIAZIDE is chlorothiazide; methyldopa. There are forty-two drug master file entries for this compound. Additional details are available on the chlorothiazide; methyldopa profile page.
Summary for METHYLDOPA AND CHLOROTHIAZIDE
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 2 |
| Formulation / Manufacturing: | see details |
| DailyMed Link: | METHYLDOPA AND CHLOROTHIAZIDE at DailyMed |
Anatomical Therapeutic Chemical (ATC) Classes for METHYLDOPA AND CHLOROTHIAZIDE
US Patents and Regulatory Information for METHYLDOPA AND CHLOROTHIAZIDE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Par Pharm | METHYLDOPA AND CHLOROTHIAZIDE | chlorothiazide; methyldopa | TABLET;ORAL | 070783-001 | Nov 6, 1987 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| Par Pharm | METHYLDOPA AND CHLOROTHIAZIDE | chlorothiazide; methyldopa | TABLET;ORAL | 070654-001 | Nov 6, 1987 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
